Cross Country Healthcare, Inc. (CCRN) P/E Ratio History
Insufficient DataValuation data unavailable. · Data 2002–2024
Loading P/E history...
P/E Ratio Analysis
For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our CCRN DCF Valuation Calculator →
Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.
CCRN Cross-Benchmark Valuation
How does the current P/E compare to sector peers and the broader market?
CCRN P/E vs Peers
Physician Groups and Staffing peers sorted by market cap
| Company | Market Cap | P/E Ratio | PEG Ratio | EPS Growth (1Y) |
|---|---|---|---|---|
| $1B | 13.3Lowest | - | +36% | |
| $2B | 16.1 | - | +53%Best | |
| $2B | 17.8 | - | -110% | |
| $1B | 20.8 | - | -32% | |
| $4B | 13.8 | 0.69Best | +13% | |
| $6B | 43.7 | 0.84 | -12% |
Lower P/E can signal a discount or weaker growth expectations; PEG adds growth context.
CCRN Historical P/E Data (2002–2024)
Quarterly P/E ratios calculated from closing price and TTM EPS
| Quarter | Period End | Price | TTM EPS | P/E Ratio | vs Avg |
|---|---|---|---|---|---|
| FY2024 Q2 | Jun 30 2024 | $13.84 | $0.23 | 60.8x | +39% |
| FY2024 Q1 | Mar 31 2024 | $18.72 | $1.30 | 14.4x | -67% |
| FY2023 Q4 | Dec 31 2023 | $22.64 | $2.03 | 11.2x | -74% |
| FY2023 Q3 | Sep 30 2023 | $24.79 | $2.82 | 8.8x | -80% |
| FY2023 Q2 | Jun 30 2023 | $28.08 | $3.39 | 8.3x | -81% |
| FY2023 Q1 | Mar 31 2023 | $22.32 | $4.19 | 5.3x | -88% |
| FY2022 Q4 | Dec 31 2022 | $26.57 | $5.01 | 5.3x | -88% |
| FY2022 Q3 | Sep 30 2022 | $28.37 | $6.03 | 4.7x | -89% |
| FY2022 Q2 | - | $20.83 | $5.72 | 3.6x | -92% |
| FY2022 Q1 | - | $21.67 | $4.63 | 4.7x | -89% |
| FY2021 Q4 | Dec 31 2021 | $27.76 | $3.53 | 7.9x | -82% |
| FY2021 Q3 | - | $21.24 | $1.59 | 13.4x | -69% |
| FY2021 Q2 | Jun 30 2021 | $16.51 | $0.93 | 17.7x | -59% |
| FY2021 Q1 | Mar 31 2021 | $12.49 | $0.23 | 53.6x | +23% |
| FY2018 Q3 | Sep 30 2018 | $8.73 | $0.85 | 10.3x | -76% |
| FY2018 Q2 | Jun 30 2018 | $11.25 | $1.05 | 10.7x | -75% |
| FY2018 Q1 | Mar 31 2018 | $11.11 | $1.14 | 9.7x | -78% |
| FY2017 Q4 | Dec 31 2017 | $12.76 | $1.03 | 12.3x | -72% |
| FY2017 Q3 | Sep 30 2017 | $14.23 | $0.02 | 571.5x | +1210% |
| FY2017 Q2 | Jun 30 2017 | $12.91 | $0.05 | 235.2x | +439% |
| FY2016 Q1 | - | $11.63 | $0.14 | 83.1x | +90% |
| FY2015 Q4 | - | $16.39 | $0.10 | 163.9x | +276% |
| FY2012 Q1 | Mar 31 2012 | $5.01 | $0.11 | 46.2x | +6% |
| FY2011 Q4 | Dec 31 2011 | $5.55 | $0.14 | 40.4x | -7% |
| FY2010 Q3 | - | $7.19 | $0.12 | 58.6x | +34% |
| FY2010 Q2 | Jun 30 2010 | $8.99 | $0.12 | 73.2x | +68% |
| FY2010 Q1 | Mar 31 2010 | $10.11 | $0.15 | 66.2x | +52% |
| FY2009 Q4 | - | $9.91 | $0.21 | 46.6x | +7% |
| FY2008 Q3 | - | $16.29 | $0.83 | 19.6x | -55% |
| FY2008 Q2 | Jun 30 2008 | $14.41 | $0.85 | 17.0x | -61% |
| FY2008 Q1 | Mar 31 2008 | $12.37 | $0.81 | 15.3x | -65% |
| FY2007 Q4 | Dec 31 2007 | $14.24 | $0.77 | 18.5x | -58% |
| FY2007 Q3 | Sep 30 2007 | $17.47 | $0.77 | 22.7x | -48% |
| FY2007 Q2 | Jun 30 2007 | $16.68 | $0.55 | 30.1x | -31% |
| FY2007 Q1 | Mar 31 2007 | $18.23 | $0.52 | 34.8x | -20% |
| FY2006 Q4 | Dec 31 2006 | $21.82 | $0.51 | 42.5x | -3% |
| FY2006 Q3 | Sep 30 2006 | $17.00 | $0.43 | 39.2x | -10% |
| FY2006 Q2 | Jun 30 2006 | $18.19 | $0.58 | 31.4x | -28% |
| FY2006 Q1 | Mar 31 2006 | $19.36 | $0.48 | 40.3x | -8% |
| FY2005 Q4 | Dec 31 2005 | $17.83 | $0.45 | 39.6x | -9% |
| FY2005 Q3 | Sep 30 2005 | $18.56 | $0.47 | 39.5x | -10% |
| FY2005 Q2 | - | $17.00 | $0.48 | 35.4x | -19% |
| FY2005 Q1 | - | $16.76 | $0.60 | 27.9x | -36% |
| FY2004 Q4 | Dec 31 2004 | $18.08 | $0.64 | 28.3x | -35% |
| FY2004 Q3 | - | $15.50 | $0.63 | 24.6x | -44% |
| FY2004 Q2 | Jun 30 2004 | $18.15 | $0.68 | 26.7x | -39% |
| FY2004 Q1 | Mar 31 2004 | $16.66 | $0.73 | 22.8x | -48% |
| FY2003 Q4 | Dec 31 2003 | $14.98 | $0.80 | 18.7x | -57% |
| FY2003 Q3 | - | $14.00 | $0.92 | 15.2x | -65% |
| FY2003 Q2 | Jun 30 2003 | $13.16 | $0.88 | 15.0x | -66% |
| FY2003 Q1 | Mar 31 2003 | $11.50 | $0.91 | 12.6x | -71% |
| FY2002 Q4 | - | $13.95 | $0.90 | 15.5x | -64% |
| FY2002 Q3 | Sep 30 2002 | $14.12 | $0.68 | 20.6x | -53% |
| FY2002 Q2 | Jun 30 2002 | $37.80 | $0.68 | 55.2x | +27% |
Average P/E for displayed period: 43.6x
CCRN Chart Terminal
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
Live Breakouts Feed
High-probability breakout stocks crossing their pivot across 5 pattern engines.
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
24+ years return with dividends reinvested.
Peer Comparison
Compare growth, multiples, and margins vs sector.
CCRN — Frequently Asked Questions
Quick answers to the most common questions about buying CCRN stock.
What is CCRN's P/E ratio?
Cross Country Healthcare, Inc. (CCRN) trailing twelve-month P/E ratio is N/A, based on TTM diluted EPS of N/A. The 5-year average P/E is 53.5x and the historical range spans 3.6x to 571.5x.
Is CCRN stock overvalued or undervalued?
CCRN current P/E: N/A. 5-year average P/E: 53.5x. Percentile: N/A.
Is CCRN stock expensive?
CCRN is fairly valued relative to its own history. The current P/E of N/A is near the 5-year average of 53.5x (N/A percentile of historical range).
What is CCRN's historical P/E range?
Over the past 5 years, CCRN's P/E ratio has ranged from 3.6x to 571.5x, with a median of 10.7x and an average of 53.5x. The current P/E of N/A places the stock at the N/A percentile of this range. Full historical data spans 2002–2024.
How does CCRN's P/E compare to the S&P 500?
CCRN current P/E: N/A. S&P 500 median P/E: 21.8x.
How does CCRN's valuation compare to Healthcare peers?
Cross Country Healthcare, Inc. P/E of N/A can be benchmarked against Healthcare peers in the comparison table on this page.
What is CCRN's PEG ratio?
CCRN PEG ratio is N/A. PEG normalises P/E by growth and helps compare stocks with different earnings trajectories.
What is CCRN's earnings yield?
CCRN earnings yield is N/A, the inverse of its N/A P/E ratio. Earnings yield represents the percentage of each dollar invested that the company earns. It can be compared directly to bond yields to assess relative attractiveness of stocks versus fixed income.